• Oscar Health posted Q2 net income attributable to shareholders of USD 361.81 million, swinging from a loss a year earlier; diluted EPS was USD 1.10.
• Revenue more than doubled to USD 4.88 billion, while operating income swung to USD 388.64 million.
• Medical loss ratio improved 11.9 percentage points to 79.2% on disciplined pricing and USD 164 million of favorable prior-period reserve development.
• Effectuated membership climbed to 2,963,002 as of June 30, up 46.9% from a year earlier.
• Oscar raised full-year 2026 operating income guidance to USD 500 million–USD 700 million, tightening its medical loss ratio view to 81.5%–82.5%.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Oscar Health Inc. published the original content used to generate this news brief on August 06, 2026, and is solely responsible for the information contained therein.